The plight of older Australians grappling with motor neurone disease (MND) has thrust the debate on euthanasia and healthcare funding into the spotlight. Glenn Rowan, a 78-year-old diagnosed with MND, faces a stark choice: either deplete his savings to fund 24/7 care or consider premature death. This dilemma is not unique to Rowan; it reflects a systemic issue within the aged care system and its impact on those with severe disabilities.
The crux of the problem lies in the funding disparity between the aged care system and the National Disability Insurance Scheme (NDIS). Australians diagnosed with MND after turning 65 are ineligible for the NDIS, which provides more comprehensive support. Instead, they are funnelled into the aged care system, which is ill-equipped to handle severe disabilities and offers significantly less funding.
Rowan's situation is dire. He pays approximately $7,000 a week out of pocket for disability support, a far cry from the roughly $300,000 or more available to those with MND on the NDIS. The aged care system's highest Support at Home package at Level 8 offers a meager $78,200 for at-home care, plus a one-off $15,000 for home modifications. This inadequate funding forces individuals like Rowan to make impossible choices, such as opting for early euthanasia.
The recent death of AFL star Neale Daniher, who fought MND until the age of 65, has brought the disease into the national consciousness. MND, which causes paralysis by damaging nerve cells in the brain and spinal cord, has a short life expectancy of about 24 months after diagnosis. This highlights the urgency of the situation, as many Australians with MND are given priority access to the NDIS, which offers more comprehensive support.
However, the aged care system's automated assessment tool, which determines funding levels, often fails to categorize individuals with MND at the highest funding level. This results in funding that barely covers basic needs, such as help with getting out of bed and having a shower, twice a week. The lack of price caps regulating the cost of at-home care services further exacerbates the issue, making it financially cripple families.
The situation is further complicated by the rapid physical deterioration of MND, which sets it apart from other neurological diseases associated with aging. The aged care residential sector is primarily designed to care for individuals with Alzheimer's disease, not those with severe physical disabilities like MND. This mismatch in care highlights the systemic issues within the healthcare system.
The government's response has been to provide urgent priority access to funding under the Support at Home program for people over 65 diagnosed with MND. While this is a step in the right direction, it does not address the fundamental issue of inadequate funding. The call for voluntary assisted dying, as accepted for Rowan, underscores the desperate measures individuals are forced to consider when faced with financial ruin and a short life prognosis.
In conclusion, the case of Glenn Rowan and others like him exposes the harsh realities of the aged care system and its impact on those with severe disabilities. The debate on euthanasia and healthcare funding must be addressed to ensure that individuals like Rowan can receive the dignity and support they deserve in their final days.
